| Literature DB >> 22089065 |
Carmen M Romero Barco1, Sara Manrique Arija, Manuel Rodríguez Pérez.
Abstract
Currently, the measurement of bone remodeling biomarkers is an innovate proposal in clinical evaluation of patients with osteoporosis. Its use may identify patients at increased risk of fracture as well as monitoring therapeutic efficacy. Because they constitute a relatively inexpensive non-invasive measurement, its use should be widespread for serial and frequent measurements of bone turnover. However, their analytical and biological variability limits their clinical applicability.Entities:
Mesh：
Substances：
Year: 2011 PMID： 22089065 DOI： 10.1016/j.reuma.2011.05.010
Source DB: PubMed Journal: Reumatol Clin ISSN： 1699-258X